Exciting advances in science have led to developing treatment breakthroughs—such as gene scripting therapies—that could represent the first potential cures for rare diseases and other life-threatening conditions. Gene therapies offer dramatic promise—but also come with high costs. When viewing gene therapies and other expensive treatment options against the backdrop of an evolving healthcare landscape, several reimbursement challenges emerge.
During the webinar, Manatt Health examines the key issues that life sciences companies should consider when developing their reimbursement strategies for high-cost therapies, as both public and private payers struggle with balancing budgets against increasing demands. The program gives you the opportunity to:
- Explore the evolving landscape of expensive yet potentially curative therapies.
- Analyze the challenges of care delivery and coordination to ensure patient access.
- Understand the coverage and reimbursement challenges for both public and private payers.
- Learn about innovative models that could potentially overcome coverage and reimbursement hurdles.